feed,title,long_url,short_url
MarketWatch,Biogen talks up approval plans for controversial Alzheimerâ€™s drug as it nears FDA decision,http://www.marketwatch.com/news/story.asp?guid=%7B21005575-02D4-D4B5-4572-D3B0E4D0A735%7D&siteid=rss&rss=1,https://on.mktw.net/2PcguJ0
